within Pharmacolibrary.Drugs.ATC.J;

model J01CF04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 9.166666666666667e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.011800000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0066,
    k12             = 16.5,
    k21             = 16.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CF04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Oxacillin is a narrow-spectrum beta-lactam antibiotic of the penicillin class, primarily used for the treatment of infections caused by penicillinase-producing staphylococci. It is still clinically approved and used especially for serious Staphylococcus aureus infections sensitive to methicillin-class drugs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Bock, M, et al., &amp; Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 77(2) 242–251. DOI:<a href=\"https://doi.org/10.1093/cid/ciad168\">10.1093/cid/ciad168</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36947131/\">https://pubmed.ncbi.nlm.nih.gov/36947131</a></p></li><li><p>Visser, LG, et al., &amp; van den Broek, PJ (1993). Clinical pharmacokinetics of continuous intravenous administration of penicillins. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 17(3) 491–495. DOI:<a href=\"https://doi.org/10.1093/clinids/17.3.491\">10.1093/clinids/17.3.491</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8218695/\">https://pubmed.ncbi.nlm.nih.gov/8218695</a></p></li><li><p>Adrianzén Vargas, MR, et al., &amp; Barron, DJ (2004). Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery. <i>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</i> 25(2) 256–260. DOI:<a href=\"https://doi.org/10.1016/j.ejcts.2003.11.017\">10.1016/j.ejcts.2003.11.017</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14747123/\">https://pubmed.ncbi.nlm.nih.gov/14747123</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CF04;
